In addition, p38 MAPK signaling enhances the effects of RANKL on the induction of osteoclast differentiation, and osteoclast-mediated bone resorption in myeloma cells triggers osteolytic bone destruction [69]. Here, TNFSF11 is linked to plasma cell myeloma.